Filing Details

Accession Number:
0000711377-20-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-01-13 18:08:21
Reporting Period:
2020-01-09
Accepted Time:
2020-01-13 18:08:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168789 L James Herbert Neogen Corp
620 Lesher Place
Lansing MI 48912
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-01-09 7,339 $65.10 49,972 No 4 S Indirect See Footnote
Common Stock Disposition 2020-01-10 10,000 $65.48 39,972 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Footnotes
  1. Shares were sold from a trust controlled by Mr. Herbert's spouse.
  2. After the sales noted from 1/9 and 1/10, Mr. Herbert and his spouse own 209 shares in limited liability companies in which they hold minority financial positions, 39,568 shares are held jointly between Mr. Herbert and his spouse, 95 shares are controlled by Mrs. Herbert in her trust, and 100 shares are held in a charitable remainder trust in which Mr. Herbert and his spouse are trustees and beneficiaries
  3. Shares were sold under the terms of a Rule 10b5-1 Plan filed by the Reporting Person on October 1, 2019